RobertW
January 20th, 2009, 09:26
http://www.urotoday.com/index.php?option=com_content&task=view_ua&id=2219756
Effect of Male Circumcision on the Prevalence of High-Risk Human Papillomavirus in Young Men: Results of a Randomized Controlled Trial Conducted in Orange Farm, South Africa - Abstract
Monday, 19 January 2009 Assistance Publique-Hôpitaux de Paris, University of Versailles, Institut National de la Santé et de la Recherche Médicale, Unité 687, France.
National Institute for Communicable Diseases and Progressus, Johannesburg, South Africa.
A causal association links high-risk human papillomavirus (HR-HPV) and cervical cancer, which is a major public health problem. The objective of the present study was to investigate the association between male circumcision (MC) and the prevalence of HR-HPV among young men.
We used data from a MC trial conducted in Orange Farm, South Africa, among men aged 18-24 years. Urethral swab samples were collected during a period of 262 consecutive days from participants in the intervention (circumcised) and control (uncircumcised) groups who were reporting for a scheduled follow-up visit. Swab samples were analyzed using polymerase chain reaction. HR-HPV prevalence rate ratios (PRRs) were assessed using univariate and multivariate log Poisson regression.
In an intention-to-treat analysis, the prevalences of HR-HPV among the intervention and control groups were 14.8% (94/637) and 22.3% (140/627), respectively, with a PRR of 0.66 (0.51-0.86) ([Formula: see text]). Controlling for propensity score and confounders (ethnic group, age, education, sexual behavior [including condom use], marital status, and human immunodeficiency virus status) had no effect on the results.
This is the first randomized controlled trial to show a reduction in the prevalence of urethral HR-HPV infection after MC. This finding explains why women with circumcised partners are at a lower risk of cervical cancer than other women. Trial registration.
Written by:
Auvert B, Sobngwi-Tambekou J, Cutler E, Nieuwoudt M, Lissouba P, Puren A, Taljaard D. Are you the author? (http://www.urotoday.com/information_for/submission_guidelines/submitting_commentary.html?s_cid=invite_abstract_b tasubmit_t)
Reference:
J Infect Dis. 2009 Jan 1;199(1):14-9. (javascript:popWin('http://www.journals.uchicago.edu/doi/abs/10.1086/595566?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov?s_cid=citation', 'width=450,height=350,left=160,top=100,scrollbars= yes,resizable=yes,toolbar=no,location=no,menubar=y es,directories=no,status=no');)
doi:10.1086/595566
PubMed Abstract (javascript:popWin('http://www.ncbi.nlm.nih.gov/pubmed/19086814?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsP anel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum?s_c id=pubmed','width=450,height=350,left=160,top=100, scrollbars=yes,resizable=yes,toolbar=no,location=n o,menubar=yes,directories=no,status=no');)
PMID:19086814
UroToday.com Sexually Transmitted Disease Section (http://www.urotoday.com/browse_categories/sexually_transmitted_disease/1199/?s_cid=invite_abstract_std_t)
http://www.urotoday.com/images/stories/logo_urotoday_sm.jpg (http://www.urotoday.com/3341/browse_categories/beyond_the_abstract/2528/?s_cid=invite_abstract_bta_b)
Effect of Male Circumcision on the Prevalence of High-Risk Human Papillomavirus in Young Men: Results of a Randomized Controlled Trial Conducted in Orange Farm, South Africa - Abstract
Monday, 19 January 2009 Assistance Publique-Hôpitaux de Paris, University of Versailles, Institut National de la Santé et de la Recherche Médicale, Unité 687, France.
National Institute for Communicable Diseases and Progressus, Johannesburg, South Africa.
A causal association links high-risk human papillomavirus (HR-HPV) and cervical cancer, which is a major public health problem. The objective of the present study was to investigate the association between male circumcision (MC) and the prevalence of HR-HPV among young men.
We used data from a MC trial conducted in Orange Farm, South Africa, among men aged 18-24 years. Urethral swab samples were collected during a period of 262 consecutive days from participants in the intervention (circumcised) and control (uncircumcised) groups who were reporting for a scheduled follow-up visit. Swab samples were analyzed using polymerase chain reaction. HR-HPV prevalence rate ratios (PRRs) were assessed using univariate and multivariate log Poisson regression.
In an intention-to-treat analysis, the prevalences of HR-HPV among the intervention and control groups were 14.8% (94/637) and 22.3% (140/627), respectively, with a PRR of 0.66 (0.51-0.86) ([Formula: see text]). Controlling for propensity score and confounders (ethnic group, age, education, sexual behavior [including condom use], marital status, and human immunodeficiency virus status) had no effect on the results.
This is the first randomized controlled trial to show a reduction in the prevalence of urethral HR-HPV infection after MC. This finding explains why women with circumcised partners are at a lower risk of cervical cancer than other women. Trial registration.
Written by:
Auvert B, Sobngwi-Tambekou J, Cutler E, Nieuwoudt M, Lissouba P, Puren A, Taljaard D. Are you the author? (http://www.urotoday.com/information_for/submission_guidelines/submitting_commentary.html?s_cid=invite_abstract_b tasubmit_t)
Reference:
J Infect Dis. 2009 Jan 1;199(1):14-9. (javascript:popWin('http://www.journals.uchicago.edu/doi/abs/10.1086/595566?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov?s_cid=citation', 'width=450,height=350,left=160,top=100,scrollbars= yes,resizable=yes,toolbar=no,location=no,menubar=y es,directories=no,status=no');)
doi:10.1086/595566
PubMed Abstract (javascript:popWin('http://www.ncbi.nlm.nih.gov/pubmed/19086814?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsP anel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum?s_c id=pubmed','width=450,height=350,left=160,top=100, scrollbars=yes,resizable=yes,toolbar=no,location=n o,menubar=yes,directories=no,status=no');)
PMID:19086814
UroToday.com Sexually Transmitted Disease Section (http://www.urotoday.com/browse_categories/sexually_transmitted_disease/1199/?s_cid=invite_abstract_std_t)
http://www.urotoday.com/images/stories/logo_urotoday_sm.jpg (http://www.urotoday.com/3341/browse_categories/beyond_the_abstract/2528/?s_cid=invite_abstract_bta_b)